Cargando…
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
BACKGROUND: Insulin is highly recommended for diabetes management in persons with liver cirrhosis. However, few studies have evaluated its long-term effects in these persons. We conducted this study to compare the risks of mortality, liver-related complications, and cardiovascular events in persons...
Autores principales: | Yen, Fu-Shun, Lai, Jung-Nien, Wei, James Cheng-Chung, Chiu, Lu-Ting, Hsu, Chih-Cheng, Hou, Ming-Chih, Hwu, Chii-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199810/ https://www.ncbi.nlm.nih.gov/pubmed/34118892 http://dx.doi.org/10.1186/s12876-021-01773-x |
Ejemplares similares
-
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2020) -
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023) -
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021) -
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
por: Yen, Fu‐Shun, et al.
Publicado: (2020)